Unknown

Dataset Information

0

Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Herishanu Y 

PROVIDER: S-EPMC8500836 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.
| S-EPMC6037466 | biostudies-literature
Unknown Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
| S-EPMC8061088 | biostudies-literature
Unknown Antibody titres decline 3-month post-vaccination with BNT162b2.
| S-EPMC8300930 | biostudies-literature
Unknown Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia.
| S-EPMC8353933 | biostudies-literature
Unknown Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.
| S-EPMC8632355 | biostudies-literature
Unknown Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
| S-EPMC9045126 | biostudies-literature
Unknown Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.
| S-EPMC8651482 | biostudies-literature
Unknown Chronic lymphocytic leukemia monitoring with a Lamprey idiotope-specific antibody.
| S-EPMC3888878 | biostudies-literature
Unknown Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
| S-EPMC5334439 | biostudies-literature
Unknown Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.
| S-EPMC8505800 | biostudies-literature